Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2006 Dec;98(12):1977–1981.

Childhood nephrotic syndrome: change in pattern and response to steroids.

Ifeoma Anochie 1, Felicia Eke 1, Augustina Okpere 1
PMCID: PMC2569667  PMID: 17225845

Abstract

BACKGROUND: In our center, childhood nephrotic syndrome (NS) had been reported for over a decade to be steroid sensitive contrary to reports in other parts of Nigeria. The purpose of this study was to determine if there are changes in presentation and response to steroids, with reviews of the literature on NS. METHODS: Analysis of 28 patients seen at the University of Port Harcourt Teaching Hospital, Nigeria, from 1999-2004 with the diagnosis of NS was performed. RESULTS: There were 14 girls and 14 boys with NS. The peak age was 1-4 years. Twenty (71.4%) children had idiopathic nephrotic syndrome (INS). Four had chronic renal failure, one had sickle cell disease (HbSS), two were positive to human immunodeficiency virus (HIV) 1 and 2, and one had pulmonary tuberculosis. Anemia was found in 13 patients, while 17 had Plasmodium falciparum. Plasmodium malariae and hepatitis-B surface antigen were not isolated. Renal biopsy was performed in four patients and revealed minimal-change disease in one child, focal segmental glomerulosclerosis in two and no conclusive result in one patient. Oral prednisolone was used in INS. After one month of therapy, 16 of 20 responded, of which 12 (75%) were <5 years. The NS relapsed in 15 of 16 steroid-sensitive patients. Cyclophosphamide and levamisole were used in four and one patients with FRNS, respectively. Four (14.3%) patients died; all were secondary NS. CONCLUSION: INS remains common in our center, and the majority respond to steroid therapy

Full text

PDF
1977

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdurrahman M. B., Edington G. M., Narayana T. P., Babaoye F. A. Pathology of childhood nephrotic syndrome in northern Nigeria. Trop Geogr Med. 1981 Sep;33(3):269–273. [PubMed] [Google Scholar]
  2. Abdurrahman M. B., Greenwood B. M., Narayana P., Babaoye F. A., Edington G. M. Immunological aspects of nephrotic syndrome in northern Nigeria. Arch Dis Child. 1981 Mar;56(3):199–202. doi: 10.1136/adc.56.3.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abdurrahman M. B. The role of infectious agents in the aetiology and pathogenesis of childhood nephrotic syndrome in Africa. J Infect. 1984 Mar;8(2):100–109. doi: 10.1016/s0163-4453(84)92356-9. [DOI] [PubMed] [Google Scholar]
  4. Adhikari M., Coovadia H. M., Chrystal V., Morel-Maroger L. Absence of 'true' minimal change nephrotic syndrome in African children in South Africa. J Trop Med Hyg. 1983 Dec;86(6):223–228. [PubMed] [Google Scholar]
  5. Adu D., Anim-Addo Y., Foli A. K., Blankson J. M., Annobil S. H., Reindorf C. A., Christian E. C. The nephrotic syndrome in Ghana: clinical and pathological aspects. Q J Med. 1981 Summer;50(199):297–306. [PubMed] [Google Scholar]
  6. Asinobi A. O., Gbadegesin R. A., Adeyemo A. A., Akang E. E., Arowolo F. A., Abiola O. A., Osinusi K. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria. West Afr J Med. 1999 Jul-Sep;18(3):203–206. [PubMed] [Google Scholar]
  7. Asinobi A. O., Gbadegesin R. A., Ogunkunle O. O. Increased steroid responsiveness of young children with nephrotic syndrome in Nigeria. Ann Trop Paediatr. 2005 Sep;25(3):199–203. doi: 10.1179/146532805X58139. [DOI] [PubMed] [Google Scholar]
  8. Babaoye F. A., Abdurrahman M. B., Narayana P. T. Childhood nephrotic syndrome in Northern Nigeria: management and follow-up of 40 patients. J Trop Pediatr. 1985 Apr;31(2):71–73. doi: 10.1093/tropej/31.2.71. [DOI] [PubMed] [Google Scholar]
  9. Bagga Arvind, Mantan Mukta. Nephrotic syndrome in children. Indian J Med Res. 2005 Jul;122(1):13–28. [PubMed] [Google Scholar]
  10. Benz Kerstin, Dötsch Jörg, Rascher Wolfgang, Stachel Daniel. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol. 2004 Apr 8;19(7):794–797. doi: 10.1007/s00467-004-1434-z. [DOI] [PubMed] [Google Scholar]
  11. Bircan Zelal, Yavuz Yilmaz Alev, Katar Selahattin, Vitrinel Ayça, Yildirim Mehmet. Childhood idiopathic nephrotic syndrome in Turkey. Pediatr Int. 2002 Dec;44(6):608–611. doi: 10.1046/j.1442-200x.2002.01628.x. [DOI] [PubMed] [Google Scholar]
  12. Churg J., Habib R., White R. H. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet. 1970 Jun 20;760(1):1299–1302. doi: 10.1016/s0140-6736(70)91905-7. [DOI] [PubMed] [Google Scholar]
  13. Coovadia H. M., Adhikari M., Morel-Maroger L. Clinico-pathological features of the nephrotic syndrome in South African children. Q J Med. 1979 Jan;48(189):77–91. [PubMed] [Google Scholar]
  14. Davin J. C., Merkus M. P. Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise? Pediatr Nephrol. 2004 Sep 17;20(1):10–14. doi: 10.1007/s00467-004-1615-9. [DOI] [PubMed] [Google Scholar]
  15. Elzouki A. Y., Amin F., Jaiswal O. P. Primary nephrotic syndrome in Arab children. Arch Dis Child. 1984 Mar;59(3):253–255. doi: 10.1136/adc.59.3.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HENDRICKSE R. G., GILLES H. M. The nephrotic syndrome and other renal diseases in children in Western Nigeria. East Afr Med J. 1963 May;40:186–201. [PubMed] [Google Scholar]
  17. Hendrickse R. G., Adeniyi A. Quartan malarial nephrotic syndrome in children. Kidney Int. 1979 Jul;16(1):64–74. doi: 10.1038/ki.1979.103. [DOI] [PubMed] [Google Scholar]
  18. Hodson Elisabeth. The management of idiopathic nephrotic syndrome in children. Paediatr Drugs. 2003;5(5):335–349. doi: 10.2165/00128072-200305050-00006. [DOI] [PubMed] [Google Scholar]
  19. Loeffler Kim, Gowrishankar Manjula, Yiu Verna. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome. Pediatr Nephrol. 2004 Feb 3;19(3):281–287. doi: 10.1007/s00467-003-1370-3. [DOI] [PubMed] [Google Scholar]
  20. McKinney P. A., Feltbower R. G., Brocklebank J. T., Fitzpatrick M. M. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001 Dec;16(12):1040–1044. doi: 10.1007/s004670100021. [DOI] [PubMed] [Google Scholar]
  21. Mori Kazuetsu, Honda Masataka, Ikeda Masahiro. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2004 Aug 18;19(11):1232–1236. doi: 10.1007/s00467-004-1584-z. [DOI] [PubMed] [Google Scholar]
  22. Musa A. R., Veress B., Kordofani A. M., Asha H. A., Satir A., el-Hassan A. M. Pattern of the nephrotic syndrome in the Sudan. Ann Trop Med Parasitol. 1980 Feb;74(1):37–44. doi: 10.1080/00034983.1980.11687308. [DOI] [PubMed] [Google Scholar]
  23. Newsom D. H., Bode H. H., Kiwanuka J., Mathieson P. W. Proteinuric renal disease in children in South-Western Uganda. QJM. 2003 May;96(5):382–384. doi: 10.1093/qjmed/hcg063. [DOI] [PubMed] [Google Scholar]
  24. Okoro B. A., Okafor H. U., Nnoli L. U. Childhood nephrotic syndrome in Enugu, Nigeria. West Afr J Med. 2000 Apr-Jun;19(2):137–141. [PubMed] [Google Scholar]
  25. Prasad Narayan, Gulati Sanjeev, Sharma Raj Kumar, Singh Uttam, Ahmed Muffazal. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2004 Mar 9;19(5):494–498. doi: 10.1007/s00467-003-1404-x. [DOI] [PubMed] [Google Scholar]
  26. Sümegi Viktória, Haszon Ibolya, Iványi Béla, Bereczki Csaba, Papp Ferenc, Túri Sándor. Long-term effects of levamisole treatment in childhood nephrotic syndrome. Pediatr Nephrol. 2004 Dec;19(12):1354–1360. doi: 10.1007/s00467-004-1608-8. [DOI] [PubMed] [Google Scholar]
  27. Takeda A., Matsutani H., Niimura F., Ohgushi H. Risk factors for relapse in childhood nephrotic syndrome. Pediatr Nephrol. 1996 Dec;10(6):740–741. doi: 10.1007/s004670050205. [DOI] [PubMed] [Google Scholar]
  28. Takeda A., Takimoto H., Mizusawa Y., Simoda M. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2001 Nov;16(11):888–893. doi: 10.1007/s004670100683. [DOI] [PubMed] [Google Scholar]
  29. Tune B. M., Mendoza S. A. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J Am Soc Nephrol. 1997 May;8(5):824–832. doi: 10.1681/ASN.V85824. [DOI] [PubMed] [Google Scholar]
  30. Ulinski Tim, Dubourg Laurence, Saïd Marie Hélène, Parchoux Bernadette, Ranchin Bruno, Cochat Pierre. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr Nephrol. 2005 Feb 18;20(4):482–485. doi: 10.1007/s00467-004-1778-4. [DOI] [PubMed] [Google Scholar]
  31. Vester Udo, Kranz Birgitta, Zimmermann Stephanie, Hoyer Peter F. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook. Pediatr Nephrol. 2003 May 16;18(7):661–664. doi: 10.1007/s00467-003-1170-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES